What does Seelos Therapeutics do?

Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in New York, focused on developing innovative therapeutic solutions for Central Nervous System (CNS) disorders and rare diseases. Founded in 2016 by Raj Mehra, Ph.D., the company aims to address significant unmet medical needs through its research and development efforts. Seelos specializes in drug discovery, clinical development, and therapeutic innovation, targeting conditions such as major depressive disorder, amyotrophic lateral sclerosis, Parkinson's disease, and various orphan diseases. Its pipeline includes several clinical-stage assets, with notable programs like SLS-002, an intranasal racemic ketamine for acute suicidal ideation, and SLS-005, a protein stabilizer for neurodegenerative diseases. The company is dedicated to providing next-generation therapeutic options for patients and healthcare providers dealing with challenging medical conditions.